医学
内皮
体内
冲程(发动机)
体外
血管内治疗
生物医学工程
外科
内科学
生物化学
机械工程
生物
工程类
生物技术
化学
动脉瘤
作者
Dayu Teng,Jeffrey S. Pannell,Robert C. Rennert,Jieying Li,Yi‐Shuan Li,Victor W. Wong,Shu Chien,Alexander A. Khalessi
出处
期刊:Stroke
[Lippincott Williams & Wilkins]
日期:2015-02-26
卷期号:46 (4): 1099-1106
被引量:124
标识
DOI:10.1161/strokeaha.114.007494
摘要
Background and Purpose— Endovascular thrombectomy has shown promise for the treatment of acute strokes resulting from large-vessel occlusion. Reperfusion-related injury may contribute to the observed decoupling of angiographic and clinical outcomes. Iatrogenic disruption of the endothelium during thrombectomy is potentially a key mediator of this process that requires further study. Methods— An in vitro live-cell platform was developed to study the effect of various commercially available endovascular devices on the endothelium. In vivo validation was performed using porcine subjects. Results— This novel in vitro platform permitted high-resolution quantification and characterization of the pattern and timing of endothelial-cell injury among endovascular thrombectomy devices and vessel diameters. Thrombectomy devices displayed heterogeneous effects on the endothelium; the device performance assessed in vitro was substantiated by in vivo findings. Conclusions— In vitro live-cell artificial vessel modeling enables a detailed study of the endothelium after thrombectomy and may contribute to future device design. Large animal studies confirm the relevance of this in vitro system to investigate endothelial physiology. This artificial vessel model may represent a practical, scalable, and physiologically relevant system to assess new endovascular technologies.
科研通智能强力驱动
Strongly Powered by AbleSci AI